Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19

• Main Authors: Jingjing Li (Author), Kai Zhang (Author), Di Wu (Author), Lianjie Ren (Author), Xinyu Chu (Author), Chao Qin (Author), Xiaopeng Han (Author), Taijun Hang (Author), Yungen Xu (Author), Lei Yang (Author), Lifang Yin (Author)
• Format: Book
• Published: Elsevier, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Strong infectivity enables coronavirus disease 2019 (COVID-19) to rage throughout the world. Moreover, the lack of drugs with definite therapeutic effects further aggravates the spread of the pandemic. Remdesivir is one of the most promising anti-severe acute respiratory syndrome coronavirus 2 (SARS...